Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
S&P 500 February Winners, Losers as Stock Benchmark Ends Monthly Journey in the Red
Wall Street Today: Market Ends Wild Political TV Day in the Green
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
Novartis Gets EU Positive Recommendation for Its Kidney Disease Treatment
Biogen, Eisai Alzheimer's Drug Sent Back for EU Nod After Safety Review